ClinicalTrials.gov
ClinicalTrials.gov Menu

PEAKS: Validation of Mobile Technologies (PEAKS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02888483
Recruitment Status : Completed
First Posted : September 5, 2016
Last Update Posted : June 26, 2018
Sponsor:
Collaborators:
National Institute on Aging (NIA)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Florida

Brief Summary:
The overall objective of this project is to evaluate and validate the accuracy and usability of a deployed beta sensor-based system. This is a cross-sectional validation study of 100 apparently health community dwelling adults aged 60+ years. Participants will perform standardized lifestyle, exercise and sedentary type physical activities in a clinic laboratory and home setting.

Condition or disease
Health Services for Persons With Disabilities Disability Evaluation Exercise Fitness Trackers Validation Studies

Detailed Description:

Wearable activity monitors have the potential to continuously and objectively measure physical activity. However, existing monitors do not address the unique challenges that face older adults, who comprise the largest segment of population who suffer from physical disabilities and dexterity issues that can make using such monitors exceedingly difficult. In fact, the majority of wearable devices on the market address the needs of three broad segments:

  1. Consumers: these devices are designed and optimized for motivated, healthy younger individuals and require pairing with smartphones to transmit data, while restricting or, at best, limiting access to raw data and algorithms.
  2. Researchers: research-focused devices tend to be validated across a wide range of studies, but are not optimized for wearability or longitudinal use.
  3. Developers: Developer-focused devices typically provide high configurability, a high- definition screen, and a variety of sensors (e.g. accelerometer, gyroscope, air pressure, light, temperature, etc.) that are suited for research and development, but are not optimized for power-efficient use.

To overcome the barriers that existing monitors impose on measuring free-living physical activity data, EveryFit developed in-home activity monitoring technology that addresses the specific and unique needs of the older population (incorporated in product called QMedic).

The overall objective of this project is to evaluate and validate the accuracy and usability of a deployed beta sensor-based system. The technology utilizes novel power-efficient engineering to continuously measure physical activity (including intensity, type and duration) in both laboratory and free-living settings. To accomplish this objective we will enroll 100 adults 60+ years of age who will perform standardized lifestyle, exercise and sedentary type physical activity in the laboratory. A subset of participants will also be asked to wear the monitor in free-living settings.

The proposed work can have far-reaching impact given the growth in the older adult population, which suffers disproportionally from chronic disease and functional impairments. Validating technology that measures physical activity continuously and accurately at the home is a critical step in scaling the system, conducting affordable population- scale studies, and maximizing the societal impact of the innovation.


Study Type : Observational
Actual Enrollment : 100 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: PEAKS: Validation of Mobile Technologies for Clinical Assessment, Monitoring and Intervention
Actual Study Start Date : July 2016
Actual Primary Completion Date : May 11, 2018
Actual Study Completion Date : May 11, 2018



Primary Outcome Measures :
  1. Metabolic equivalent (MET) value [ Time Frame: within one month ]
    MET value of physical activities defined as the oxygen uptake (VO2 = milliliter• min-1•kg-1) during a steady state rate expressed as a function 3.5 milliliter• min-1•kg-1.


Secondary Outcome Measures :
  1. Tradeoff Accuracy in metabolic equivalent estimation and power consumption [ Time Frame: within one month ]
    We will manipulate the state machine that samples data from the device with different duty cycles based on contextual changes as measured by the accelerometer or classified by models that use the accelerometer data to classify behavior or categories of behavior.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Community dwelling population
Criteria

Inclusion Criteria:

  • Age 60+ years old
  • Community dwelling adults without significant health issues that would impact safety of participation
  • Willingness to undergo all testing procedures
  • Weight stable for at least three months
  • Able to understand and speak English

Exclusion Criteria:

  • Failure to provide informed consent
  • Use of walker (use of a cane is permitted)
  • Lower extremity amputation
  • Develops chest pain or severe shortness of breath during physical stress
  • Post-stroke syndrome causing ambulatory deficits (other stroke survivors permitted)
  • Needs assistance with basic activities of daily living: feeding, dressing, continence, bathing, toileting, and transferring from a bed to a chair or from a chair to walking
  • Lives in a nursing home; persons living in assisted or independent housing are not excluded
  • Heavy drinking as drinking 5 or more drinks on the same occasion on each of 5 or more days in the past 30 days.
  • For women who are child-bearing age (up to 62 years of age): pregnancy or breast-feeding
  • Participation in a structured weight loss program or fad diet in the last month
  • Weight reduction surgery in the past year
  • Known neuromuscular disorder that restricts activity (e.g. Rhabdomyolysis, Myasthenia Gravis, Ataxia, Apraxia, post-polio syndrome, mitochondrial myopathy, etc.)
  • Diagnosed neuropathy that causes pain that restricts activity
  • Symptomatic peripheral arterial disease that restricts activity
  • Unable to communicate because of severe hearing loss or speech disorder
  • Severe visual impairment, which would preclude completion of the assessments
  • Progressive, degenerative neurologic disease (e.g., Parkinson's Disease, Multiple Sclerosis, ALS)
  • Severe rheumatologic or orthopedic diseases that significantly restricts activity (e.g., awaiting joint replacement, active inflammatory disease)
  • Terminal illness, as determined by a physician
  • Severe pulmonary disease, requiring the use of supplemental oxygen or steroid therapy
  • Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, recent history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
  • Other significant comorbid disease discovered during medical screening that would elicit safety concerns, (e.g. renal failure on hemodialysis, psychiatric disorder, chronic fatigue syndrome, etc.)
  • Pacemakers and implanted cardiac defibrillators

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02888483


Locations
United States, Florida
UF Institute on Aging Clinical and Translational Research Building
Gainesville, Florida, United States, 32611
Sponsors and Collaborators
University of Florida
National Institute on Aging (NIA)
National Cancer Institute (NCI)
Investigators
Principal Investigator: Todd M Manini, PhD University of Florida

Additional Information:
Responsible Party: University of Florida
ClinicalTrials.gov Identifier: NCT02888483     History of Changes
Other Study ID Numbers: IRB201600822 - N
5R01AG042525-05 ( U.S. NIH Grant/Contract )
SBIR HHSN261201500014C ( Other Grant/Funding Number: National Cancer Institute )
First Posted: September 5, 2016    Key Record Dates
Last Update Posted: June 26, 2018
Last Verified: June 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of Florida:
physical activity
energy expenditure